281MO Quality of life and neurocognitive function in patients with active brain metastases of HER2-positive breast cancer treated with trastuzumab-deruxtecan: Secondary endpoint analysis of the prospective single-arm phase II TUXEDO-1 trial
| Autor: | Starzer, A.M., Berghoff, A.S.S., Furtner, J., Marhold, M., Bergen, E.S., Roider-Schur, S., Forstner, H., Rottenmanner, B., Dieckmann, K., Bago-Horvath, Z., Widhalm, G., Ilhan-Mutlu, A., Minichsdorfer, C., Fuereder, T., Gruenberger, B., Singer, C., Weltermann, A., R. Puhr, Preusser, M., Bartsch, R. |
|---|---|
| Zdroj: | In Annals of Oncology September 2022 33 Supplement 7:S668-S668 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|